Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
Abstract Although several potent bile acid Farnesoid X receptor (FXR) and Takeda G-protein-coupled receptor 5 (TGR5, GPBAR1) dual agonists such as INT-767 have been reported, no non-bile acid FXR/TGR5 dual agonist has been investigated to date. Therefore, we attempted to discover potent non-bile aci...
Guardado en:
Autores principales: | Sachiho Miyata, Yuji Kawashima, Miku Sakai, Masaya Matsubayashi, Keisuke Motoki, Yui Miyajima, Yousuke Watanabe, Noriko Chikamatsu, Tetsuya Taniguchi, Ryukou Tokuyama |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f20bd812afb4befbc78eaa3e510a946 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
por: Tsuneyuki Miyazaki, et al.
Publicado: (2021) -
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Jiyu Zhou, et al.
Publicado: (2020) -
Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1/3 and ABCG2
por: Tetsuya Taniguchi, et al.
Publicado: (2021) -
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
por: Natalia Gomez-Ospina, et al.
Publicado: (2016) -
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation.
por: Barbara Renga, et al.
Publicado: (2013)